Combination Therapy Could Expand Treatment Options for AML Patients, Extend Survival
Proteasome inhibitors have proven highly effective in multiple myeloma but not in acute myeloid leukemia. The addition of a drug that inactivates the HSF1 pathway or impairs autophagy could change that.